Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse.

ABSTRACT:

SUBMITTER: Kent A 

PROVIDER: S-EPMC7362348 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature